Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Fast tracking drug development by early screening for tumour-agnostic potential: Trialist, sponsor and regulator views

The clinical/academia perspective

Date

05 Mar 2025

Session

Fast tracking drug development by early screening for tumour-agnostic potential: Trialist, sponsor and regulator views

Topics

Clinical Research;  Targeted Therapy;  Genetic and Genomic Testing;  Immunotherapy;  Rare Cancers

Tumour Site

Presenters

Stefan Michiels

Authors

S. Michiels

Author affiliations

  • Team Oncostat, Cesp, Institut Gustave Roussy, 94805 - Villejuif/FR

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.